Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

The US FDA has granted full approval to Moderna’s COVID-19 vaccine Spikevax for use in children aged six months to 11 years ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

Moderna's Spikevax was previously available for paediatric populations under emergency use authorisation. Moderna expects to make its updated vaccine available for eligible  US population for the 2025 ...

Intense throat pain is a key symptom of COVID-19 variant NB.1.8.1, referred to as "razor blade throat." Here's what to know.

As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...

Here's what is known about the new Covid XFG, or 'Stratus', variant from UK cases and symptoms to what the World Health Organisation has said ...

The next stage of the UK Covid-19 Inquiry is looking at the adult social care sector in England, Scotland, Wales and Northern ...

Starting today, the inquest will hear from everyday people about what the government's decisions over vaccines and lockdowns ...

Karnataka CM's claim on vaccine-linked heart deaths faces expert rebuttal. Health authorities stress no scientific evidence ...

Variant NB.1.8.1 accounted for 0% of U.S. cases in April. By mid-June, it was estimated to be the cause of around 37% of ...

The Royal Commission heard of the profound impacts on small to medium businesses coping with public health restrictions ...